LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Cantor Global Healthcare Conference 2026

Format: Fireside Chat & 1x1 Meetings

Date: Wednesday, September 9, 2026

Time: 9:45 AM EDT

Webcast Link: Here

H.C. Wainwright 28^th Annual Global Investment Conference

Format: Company Presentation & 1x1 Meetings

Date: Monday, September 14, 2026

Time: 11:00 AM EDT

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

A live webcast of the Cantor fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference.

About Equillium

Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact

PJ Kelleher

LifeSci Advisors, LLC

+1-617-430-7579

pkelleher@lifesciadvisors.com